SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS

Authors
ARVANITIS L MILLER BG LINK CGG
Citation
L. Arvanitis et al., SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS, Schizophrenia research, 15(1-2), 1995, pp. 142-142
Citations number
NO
Categorie Soggetti
Psychiatry,"Clinical Neurology",Psychiatry,"Clinical Neurology
Journal title
Schizophrenia research → ACNP
ISSN journal
09209964
Volume
15
Issue
1-2
Year of publication
1995
Pages
142 - 142
Database
ISI
SICI code
0920-9964(1995)15:1-2<142:S(-ANA>2.0.ZU;2-I